- Topics
- Regions
- Events
- Webcasts
- Resources
- CW Exclusives
- Membership
“For tracking litigation, enforcement, and regulatory developments, Compliance Week
should be your prime source.”- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Are pharma firms set for increased scrutiny?
How pharmaceutical firms price their products is getting a lot of additional attention in the United Kingdom and United States. Neil Hodge reports.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
OpinionWhy are CFOs struggling to stay compliant?
CFOs are tasked with overseeing an organization’s entire financial processes, not least ensuring that financial operations remain compliant with the multitude of global regulations. It’s a heavy burden to carry that might be alleviated slightly with the help of artificial intelligence, writes Markus Hornburg, head of compliance at Basware.
-
Premium'Measured approach' or light-handed GPDR? Noyb reports only 1.3 percent of EU cases result in fine
When Europe’s strict set of data protection rules came into force nearly seven years ago, privacy campaigners, industry experts, and lawyers all warned that noncompliance could result in eye-watering fines and other costly sanctions, especially for repeated breaches. However, the reality appears to be very different.
-
PremiumU.K. Employment Rights Bill promises to thwart forced labor through new consolidated regulator
For the past decade, the United Kingdom has tried to make companies more directly accountable for forced labor in their supply chains. But lawyers warn that the government’s latest plans to beef up protections against worker violations risk being heavily watered down and poorly policed by regulators.